{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:37:08Z","timestamp":1794256628152,"version":"4.9.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T00:00:00Z","timestamp":1747008000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100009703","name":"Fondazione per la Ricerca Biomedica","doi-asserted-by":"publisher","award":["1737591"],"award-info":[{"award-number":["1737591"]}],"id":[{"id":"10.13039\/501100009703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Fondazione Cariplo","doi-asserted-by":"publisher","award":["2016-0428"],"award-info":[{"award-number":["2016-0428"]}],"id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["Ricerca Corrente 2024"],"award-info":[{"award-number":["Ricerca Corrente 2024"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"DOI":"10.1186\/s40478-025-02015-x","type":"journal-article","created":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T09:23:56Z","timestamp":1747041836000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up \u03b1-synuclein fibrils"],"prefix":"10.1186","volume":"13","author":[{"given":"Alice","family":"Filippini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Carini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Barbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Gennarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6151-2451","authenticated-orcid":false,"given":"Isabella","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,12]]},"reference":[{"key":"2015_CR1","doi-asserted-by":"publisher","unstructured":"Albanese F, Mercatelli D, Finetti L et al (2021) Constitutive Silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo. Neurobiol Dis 159. https:\/\/doi.org\/10.1016\/J.NBD.2021.105487","DOI":"10.1016\/J.NBD.2021.105487"},{"key":"2015_CR2","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281\u2013297. https:\/\/doi.org\/10.1016\/S0092-8674(04)00045-5","journal-title":"Cell"},{"key":"2015_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.nbd.2017.03.007","volume":"109","author":"G Bieri","year":"2018","unstructured":"Bieri G, Gitler AD, Brahic M (2018) Internalization, axonal transport and release of fibrillar forms of alpha-synuclein. Neurobiol Dis 109:219\u2013225. https:\/\/doi.org\/10.1016\/j.nbd.2017.03.007","journal-title":"Neurobiol Dis"},{"key":"2015_CR4","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.bbadis.2008.09.015","volume":"1792","author":"S Biskup","year":"2009","unstructured":"Biskup S, West AB (2009) Zeroing in on LRRK2-linked pathogenic mechanisms in Parkinson\u2019s disease. Biochim Biophys Acta - Mol Basis Dis 1792:625\u2013633","journal-title":"Biochim Biophys Acta - Mol Basis Dis"},{"key":"2015_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/FEBS.16099","author":"L Bonet-Ponce","year":"2021","unstructured":"Bonet-Ponce L, Cookson MR (2021) LRRK2 recruitment, activity, and function in organelles. FEBS J. https:\/\/doi.org\/10.1111\/FEBS.16099","journal-title":"FEBS J"},{"key":"2015_CR6","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tins.2017.04.001","volume":"40","author":"HDE Booth","year":"2017","unstructured":"Booth HDE, Hirst WD, Wade-Martins R (2017) The role of astrocyte dysfunction in Parkinson\u2019s disease pathogenesis. Trends Neurosci 40:358\u2013370","journal-title":"Trends Neurosci"},{"key":"2015_CR7","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00401-007-0244-3","volume":"114","author":"H Braak","year":"2007","unstructured":"Braak H, Sastre M, Del Tredici K (2007) Development of alpha-synuclein immunoreactive astrocytes in the forebrain parallels stages of intraneuronal pathology in sporadic Parkinson\u2019s disease. Acta Neuropathol 114:231\u2013241. https:\/\/doi.org\/10.1007\/s00401-007-0244-3","journal-title":"Acta Neuropathol"},{"key":"2015_CR8","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/NAR\/GKZ757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X (2020) MiRDB: an online database for prediction of functional MicroRNA targets. Nucleic Acids Res 48:D127\u2013D131. https:\/\/doi.org\/10.1093\/NAR\/GKZ757","journal-title":"Nucleic Acids Res"},{"key":"2015_CR9","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/NEUP.12812","volume":"42","author":"CJ Choong","year":"2022","unstructured":"Choong CJ, Mochizuki H (2022) Neuropathology of alpha-synuclein in Parkinson\u2019s disease. Neuropathology 42:93\u2013103. https:\/\/doi.org\/10.1111\/NEUP.12812","journal-title":"Neuropathology"},{"key":"2015_CR10","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/S1474-4422(06)70471-9","volume":"5","author":"LM de Lau","year":"2006","unstructured":"de Lau LM, Breteler MM (2006) Epidemiology of Parkinson\u2019s disease. Lancet Neurol 5:525\u2013535. https:\/\/doi.org\/10.1016\/S1474-4422(06)70471-9","journal-title":"Lancet Neurol"},{"key":"2015_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/nan.12298","volume":"42","author":"K Del Tredici","year":"2016","unstructured":"Del Tredici K, Braak H (2016) Review: sporadic Parkinson\u2019s disease: development and distribution of alpha-synuclein pathology. Neuropathol Appl Neurobiol 42:33\u201350. https:\/\/doi.org\/10.1111\/nan.12298","journal-title":"Neuropathol Appl Neurobiol"},{"key":"2015_CR12","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/J.STEMCR.2018.12.011","volume":"12","author":"A di Domenico","year":"2019","unstructured":"di Domenico A, Carola G, Calatayud C et al (2019) Patient-Specific iPSC-Derived astrocytes contribute to Non-Cell-Autonomous neurodegeneration in Parkinson\u2019s disease. Stem Cell Rep 12:213\u2013229. https:\/\/doi.org\/10.1016\/J.STEMCR.2018.12.011","journal-title":"Stem Cell Rep"},{"key":"2015_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/J.PARKRELDIS.2015.11.014","volume":"22","author":"H Ding","year":"2016","unstructured":"Ding H, Huang Z, Chen M et al (2016) Identification of a panel of five serum MiRNAs as a biomarker for Parkinson\u2019s disease. Parkinsonism Relat Disord 22:68\u201373. https:\/\/doi.org\/10.1016\/J.PARKRELDIS.2015.11.014","journal-title":"Parkinsonism Relat Disord"},{"key":"2015_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/S10571-019-00649-9","volume":"39","author":"A Filippini","year":"2019","unstructured":"Filippini A, Gennarelli M, Russo I (2019) alpha-synuclein and glia in Parkinson\u2019s disease: A beneficial or a detrimental duet for the Endo-Lysosomal system?? Cell Mol Neurobiol 39:161\u2013168. https:\/\/doi.org\/10.1007\/S10571-019-00649-9","journal-title":"Cell Mol Neurobiol"},{"key":"2015_CR15","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1002\/GLIA.23920","volume":"69","author":"A Filippini","year":"2021","unstructured":"Filippini A, Mutti V, Faustini G et al (2021) Extracellular clusterin limits the uptake of alpha-synuclein fibrils by murine and human astrocytes. Glia 69:681\u2013696. https:\/\/doi.org\/10.1002\/GLIA.23920","journal-title":"Glia"},{"key":"2015_CR16","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1042\/BST20201092","volume":"49","author":"A Filippini","year":"2021","unstructured":"Filippini A, Gennarelli M, Russo I (2021) Leucine-rich repeat kinase 2-related functions in GLIA: an update of the last years. Biochem Soc Trans 49:1375\u20131384. https:\/\/doi.org\/10.1042\/BST20201092","journal-title":"Biochem Soc Trans"},{"key":"2015_CR17","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3389\/fnins.2019.00164","volume":"13","author":"EM Foster","year":"2019","unstructured":"Foster EM, Dangla-Valls A, Lovestone S et al (2019) Clusterin in Alzheimer\u2019s disease: mechanisms, genetics, and lessons from other pathologies. Front Neurosci 13:164. https:\/\/doi.org\/10.3389\/fnins.2019.00164","journal-title":"Front Neurosci"},{"key":"2015_CR18","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1038\/NATURE09191","volume":"466","author":"S Gehrke","year":"2010","unstructured":"Gehrke S, Imai Y, Sokol N, Lu B (2010) Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression. Nature 466:637\u2013641. https:\/\/doi.org\/10.1038\/NATURE09191","journal-title":"Nature"},{"key":"2015_CR19","doi-asserted-by":"publisher","first-page":"3490","DOI":"10.1007\/S12035-017-0570-Y","volume":"55","author":"L Gonzalez-Cano","year":"2018","unstructured":"Gonzalez-Cano L, Menzl I, Tisserand J et al (2018) Parkinson\u2019s Disease-Associated mutant LRRK2-Mediated Inhibition of MiRNA activity is antagonized by TRIM32. Mol Neurobiol 55:3490\u20133498. https:\/\/doi.org\/10.1007\/S12035-017-0570-Y","journal-title":"Mol Neurobiol"},{"key":"2015_CR20","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/JES.0B013E3182798A95","volume":"41","author":"CA Goodman","year":"2013","unstructured":"Goodman CA, Hornberger TA (2013) Measuring protein synthesis with sunset: a valid alternative to traditional techniques? Exerc Sport Sci Rev 41:107\u2013115. https:\/\/doi.org\/10.1097\/JES.0B013E3182798A95","journal-title":"Exerc Sport Sci Rev"},{"key":"2015_CR21","doi-asserted-by":"publisher","unstructured":"He S, Huang L, Shao C et al (2021) Several MiRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson\u2019s disease. Transl Neurodegener 10. https:\/\/doi.org\/10.1186\/S40035-021-00249-Y","DOI":"10.1186\/S40035-021-00249-Y"},{"key":"2015_CR22","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG, Falchi M, O\u2019Sullivan SS et al (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol 7:583\u2013590. https:\/\/doi.org\/10.1016\/S1474-4422(08)70117-0","journal-title":"Lancet Neurol"},{"key":"2015_CR23","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1093\/HMG\/DDR348","volume":"20","author":"MC Herzig","year":"2011","unstructured":"Herzig MC, Kolly C, Persohn E et al (2011) LRRK2 protein levels are determined by kinase function and are crucial for kidney and lung homeostasis in mice. Hum Mol Genet 20:4209\u20134223. https:\/\/doi.org\/10.1093\/HMG\/DDR348","journal-title":"Hum Mol Genet"},{"key":"2015_CR24","doi-asserted-by":"publisher","unstructured":"Hoss AG, Labadorf A, Beach TG et al (2016) MicroRNA profiles in Parkinson\u2019s disease prefrontal cortex. Front Aging Neurosci 8. https:\/\/doi.org\/10.3389\/FNAGI.2016.00036","DOI":"10.3389\/FNAGI.2016.00036"},{"key":"2015_CR25","doi-asserted-by":"publisher","unstructured":"Iannotta L, Biosa A, Kluss JH et al (2020) Divergent effects of G2019S and R1441C LRRK2 mutations on LRRK2 and Rab10 phosphorylations in mouse tissues. Cells 9. https:\/\/doi.org\/10.3390\/cells9112344","DOI":"10.3390\/cells9112344"},{"key":"2015_CR26","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1038\/EMBOJ.2008.163","volume":"27","author":"Y Imai","year":"2008","unstructured":"Imai Y, Gehrke S, Wang HQ et al (2008) Phosphorylation of 4E-BP by LRRK2 affects the maintenance of dopaminergic neurons in Drosophila. EMBO J 27:2432\u20132443. https:\/\/doi.org\/10.1038\/EMBOJ.2008.163","journal-title":"EMBO J"},{"key":"2015_CR27","doi-asserted-by":"publisher","first-page":"D239","DOI":"10.1093\/NAR\/GKX1141","volume":"46","author":"D Karagkouni","year":"2018","unstructured":"Karagkouni D, Paraskevopoulou MD, Chatzopoulos S et al (2018) DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions. Nucleic Acids Res 46:D239\u2013D245. https:\/\/doi.org\/10.1093\/NAR\/GKX1141","journal-title":"Nucleic Acids Res"},{"key":"2015_CR28","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/J.STEM.2020.08.002","volume":"27","author":"JW Kim","year":"2020","unstructured":"Kim JW, Yin X, Jhaldiyal A et al (2020) Defects in mRNA translation in LRRK2-Mutant hiPSC-Derived dopaminergic neurons lead to dysregulated calcium homeostasis. Cell Stem Cell 27:633\u2013645e7. https:\/\/doi.org\/10.1016\/J.STEM.2020.08.002","journal-title":"Cell Stem Cell"},{"key":"2015_CR29","doi-asserted-by":"publisher","unstructured":"Kim JW, Yin X, Martin I et al (2021) Dysregulated mRNA translation in the G2019S LRRK2 and LRRK2 Knock-Out mouse brains. https:\/\/doi.org\/10.1523\/ENEURO.0310-21.2021. eNeuro 8:","DOI":"10.1523\/ENEURO.0310-21.2021"},{"key":"2015_CR30","doi-asserted-by":"publisher","first-page":"9262","DOI":"10.1074\/jbc.M109.081125","volume":"285","author":"H-J Lee","year":"2010","unstructured":"Lee H-J, Suk J-E, Patrick C et al (2010) Direct transfer of alpha-synuclein from neuron to astroglia causes inflammatory responses in synucleinopathies. J Biol Chem 285:9262\u20139272. https:\/\/doi.org\/10.1074\/jbc.M109.081125","journal-title":"J Biol Chem"},{"key":"2015_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.mcn.2017.04.009","volume":"82","author":"V Lindstr\u00f6m","year":"2017","unstructured":"Lindstr\u00f6m V, Gustafsson G, Sanders LH et al (2017) Extensive uptake of alpha-synuclein oligomers in astrocytes results in sustained intracellular deposits and mitochondrial damage. Mol Cell Neurosci 82:143\u2013156. https:\/\/doi.org\/10.1016\/j.mcn.2017.04.009","journal-title":"Mol Cell Neurosci"},{"key":"2015_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.3390\/biom5020435","volume":"5","author":"T Lopes da Fonseca","year":"2015","unstructured":"Lopes da Fonseca T, Villar-Piqu\u00e9 A, Outeiro T (2015) The interplay between Alpha-Synuclein clearance and spreading. Biomolecules 5:435\u2013471. https:\/\/doi.org\/10.3390\/biom5020435","journal-title":"Biomolecules"},{"key":"2015_CR33","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00401-017-1746-2","volume":"134","author":"F Loria","year":"2017","unstructured":"Loria F, Vargas JY, Bousset L et al (2017) alpha-synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading. Acta Neuropathol 134:789\u2013808. https:\/\/doi.org\/10.1007\/s00401-017-1746-2","journal-title":"Acta Neuropathol"},{"key":"2015_CR34","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12868-016-0315-2","volume":"17","author":"T Maekawa","year":"2016","unstructured":"Maekawa T, Sasaoka T, Azuma S et al (2016) Leucine-rich repeat kinase 2 (LRRK2) regulates alpha-synuclein clearance in microglia. BMC Neurosci 17:77. https:\/\/doi.org\/10.1186\/s12868-016-0315-2","journal-title":"BMC Neurosci"},{"key":"2015_CR35","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/J.JBIOTEC.2011.01.023","volume":"152","author":"R Margis","year":"2011","unstructured":"Margis R, Margis R, Rieder CRM (2011) Identification of blood MicroRNAs associated to parkinson\u012ds disease. J Biotechnol 152:96\u2013101. https:\/\/doi.org\/10.1016\/J.JBIOTEC.2011.01.023","journal-title":"J Biotechnol"},{"key":"2015_CR36","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/ANNUREV-GENOM-082410-101440","volume":"12","author":"I Martin","year":"2011","unstructured":"Martin I, Dawson VL, Dawson TM (2011) Recent advances in the genetics of Parkinson\u2019s disease. Annu Rev Genomics Hum Genet 12:301\u2013325. https:\/\/doi.org\/10.1146\/ANNUREV-GENOM-082410-101440","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"2015_CR37","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/JNC.12949","volume":"131","author":"I Martin","year":"2014","unstructured":"Martin I, Kim JW, Dawson VL, Dawson TM (2014) LRRK2 pathobiology in Parkinson\u2019s disease. J Neurochem 131:554\u2013565. https:\/\/doi.org\/10.1111\/JNC.12949","journal-title":"J Neurochem"},{"key":"2015_CR38","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/J.CELL.2014.01.064","volume":"157","author":"I Martin","year":"2014","unstructured":"Martin I, Kim JW, Lee BD et al (2014) Ribosomal protein s15 phosphorylation mediates LRRK2 neurodegeneration in Parkinson\u2019s disease. Cell 157:472\u2013485. https:\/\/doi.org\/10.1016\/J.CELL.2014.01.064","journal-title":"Cell"},{"key":"2015_CR39","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4161\/19336934.2014.983382","volume":"8","author":"I Martin","year":"2014","unstructured":"Martin I, Abalde-Atristain L, Kim JW et al (2014) Abberant protein synthesis in G2019S LRRK2 Drosophila Parkinson disease-related phenotypes. Fly (Austin) 8:165\u2013169. https:\/\/doi.org\/10.4161\/19336934.2014.983382","journal-title":"Fly (Austin)"},{"key":"2015_CR40","doi-asserted-by":"publisher","unstructured":"McGeary SE, Lin KS, Shi CY et al (2019) The biochemical basis of MicroRNA targeting efficacy. Science 366. https:\/\/doi.org\/10.1126\/SCIENCE.AAV1741","DOI":"10.1126\/SCIENCE.AAV1741"},{"key":"2015_CR41","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1097\/01.jnen.0000235121.98052.54","volume":"65","author":"J Miklossy","year":"2006","unstructured":"Miklossy J, Arai T, Guo JP et al (2006) LRRK2 expression in normal and pathologic human brain and in human cell lines. J Neuropathol Exp Neurol 65:953\u2013963. https:\/\/doi.org\/10.1097\/01.jnen.0000235121.98052.54","journal-title":"J Neuropathol Exp Neurol"},{"key":"2015_CR42","doi-asserted-by":"publisher","unstructured":"Mingardi J, La Via L, Tornese P et al (2021) miR-9-5p is involved in the rescue of stress-dependent dendritic shortening of hippocampal pyramidal neurons induced by acute antidepressant treatment with ketamine. Neurobiol Stress 15. https:\/\/doi.org\/10.1016\/J.YNSTR.2021.100381","DOI":"10.1016\/J.YNSTR.2021.100381"},{"key":"2015_CR43","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0165-5728(94)00194-S","volume":"58","author":"TE Morgan","year":"1995","unstructured":"Morgan TE, Laping NJ, Rozovsky I et al (1995) Clusterin expression by astrocytes is influenced by transforming growth factor \u03921 and heterotypic cell interactions. J Neuroimmunol 58:101\u2013110. https:\/\/doi.org\/10.1016\/0165-5728(94)00194-S","journal-title":"J Neuroimmunol"},{"key":"2015_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/JPD-130192","volume":"3","author":"C Pais\u00e1n-Ruiz","year":"2013","unstructured":"Pais\u00e1n-Ruiz C, Lewis PA, Singleton AB (2013) LRRK2: cause, risk, and mechanism. J Parkinsons Dis 3:85\u2013103","journal-title":"J Parkinsons Dis"},{"key":"2015_CR45","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1002\/cne.903390307","volume":"339","author":"GM Pasinetti","year":"1994","unstructured":"Pasinetti GM, Johnson SA, Oda T et al (1994) Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J Comp Neurol 339:387\u2013400. https:\/\/doi.org\/10.1002\/cne.903390307","journal-title":"J Comp Neurol"},{"key":"2015_CR46","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12974-015-0449-7","volume":"12","author":"I Russo","year":"2015","unstructured":"Russo I, Berti G, Plotegher N et al (2015) Leucine-rich repeat kinase 2 positively regulates inflammation and down-regulates NF-\u03baB p50 signaling in cultured microglia cells. J Neuroinflammation 12:230. https:\/\/doi.org\/10.1186\/s12974-015-0449-7","journal-title":"J Neuroinflammation"},{"key":"2015_CR47","doi-asserted-by":"publisher","unstructured":"Russo I, Di Benedetto G, Kaganovich A et al (2018) Leucine-rich repeat kinase 2 controls protein kinase A activation state through phosphodiesterase 4. J Neuroinflammation 15. https:\/\/doi.org\/10.1186\/s12974-018-1337-8","DOI":"10.1186\/s12974-018-1337-8"},{"key":"2015_CR48","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.nbd.2019.05.012","volume":"129","author":"I Russo","year":"2019","unstructured":"Russo I, Kaganovich A, Ding J et al (2019) Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with alpha-synuclein fibrils. Neurobiol Dis 129:67\u201378. https:\/\/doi.org\/10.1016\/j.nbd.2019.05.012","journal-title":"Neurobiol Dis"},{"key":"2015_CR49","doi-asserted-by":"publisher","first-page":"105724","DOI":"10.1016\/J.NBD.2022.105724","volume":"169","author":"I Russo","year":"2022","unstructured":"Russo I, Bubacco L, Greggio E (2022) LRRK2 as a target for modulating immune system responses. Neurobiol Dis 169:105724. https:\/\/doi.org\/10.1016\/J.NBD.2022.105724","journal-title":"Neurobiol Dis"},{"key":"2015_CR50","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1038\/ng.485","volume":"41","author":"W Satake","year":"2009","unstructured":"Satake W, Nakabayashi Y, Mizuta I et al (2009) Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson\u2019s disease. Nat Genet 41:1303\u20131307. https:\/\/doi.org\/10.1038\/ng.485","journal-title":"Nat Genet"},{"key":"2015_CR51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/NMETH.1314","volume":"6","author":"EK Schmidt","year":"2009","unstructured":"Schmidt EK, Clavarino G, Ceppi M, Pierre P (2009) SUnSET, a nonradioactive method to monitor protein synthesis. Nat Methods 6:275\u2013277. https:\/\/doi.org\/10.1038\/NMETH.1314","journal-title":"Nat Methods"},{"key":"2015_CR52","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini MG, Schmidt ML, Lee VM et al (1997) Alpha-synuclein in lewy bodies. Nature 388:839\u2013840. https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"key":"2015_CR53","doi-asserted-by":"publisher","unstructured":"Sticht C, De La Torre C, Parveen A, Gretz N (2018) MiRWalk: an online resource for prediction of MicroRNA binding sites. PLoS ONE 13. https:\/\/doi.org\/10.1371\/JOURNAL.PONE.0206239","DOI":"10.1371\/JOURNAL.PONE.0206239"},{"key":"2015_CR54","doi-asserted-by":"publisher","first-page":"3119","DOI":"10.1007\/s12035-021-02327-8","volume":"58","author":"L Streubel-Gallasch","year":"2021","unstructured":"Streubel-Gallasch L, Giusti V, Sandre M et al (2021) Parkinson\u2019s Disease-Associated LRRK2 interferes with Astrocyte-Mediated Alpha-Synuclein clearance. Mol Neurobiol 58:3119\u20133140. https:\/\/doi.org\/10.1007\/s12035-021-02327-8","journal-title":"Mol Neurobiol"},{"key":"2015_CR55","doi-asserted-by":"publisher","first-page":"9879","DOI":"10.1073\/PNAS.1004676107","volume":"107","author":"Y Tong","year":"2010","unstructured":"Tong Y, Yamaguchi H, Giaime E et al (2010) Loss of leucine-rich repeat kinase 2 causes impairment of protein degradation pathways, accumulation of alpha-synuclein, and apoptotic cell death in aged mice. Proc Natl Acad Sci U S A 107:9879\u20139884. https:\/\/doi.org\/10.1073\/PNAS.1004676107","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2015_CR56","doi-asserted-by":"crossref","unstructured":"Tremblay ME, Cookson MR, Civiero L (2019) Glial phagocytic clearance in Parkinson\u2019s disease. Mol Neurodegener 14","DOI":"10.1186\/s13024-019-0314-8"},{"key":"2015_CR57","doi-asserted-by":"publisher","first-page":"8618","DOI":"10.1523\/JNEUROSCI.0954-20.2020","volume":"40","author":"T Tsunemi","year":"2020","unstructured":"Tsunemi T, Ishiguro Y, Yoroisaka A et al (2020) Astrocytes protect human dopaminergic neurons from alpha-synuclein accumulation and propagation. J Neurosci 40:8618\u20138628. https:\/\/doi.org\/10.1523\/JNEUROSCI.0954-20.2020","journal-title":"J Neurosci"},{"key":"2015_CR58","doi-asserted-by":"publisher","unstructured":"Uwatoko H, Hama Y, Iwata IT et al (2019) Identification of plasma MicroRNA expression changes in multiple system atrophy and Parkinson\u2019s disease. Mol Brain 12. https:\/\/doi.org\/10.1186\/S13041-019-0471-2","DOI":"10.1186\/S13041-019-0471-2"},{"key":"2015_CR59","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/PL00007400","volume":"99","author":"K Wakabayashi","year":"2000","unstructured":"Wakabayashi K, Hayashi S, Yoshimoto M et al (2000) NACP\/alpha-synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson\u2019s disease brains. Acta Neuropathol 99:14\u201320. https:\/\/doi.org\/10.1007\/PL00007400","journal-title":"Acta Neuropathol"},{"key":"2015_CR60","doi-asserted-by":"publisher","unstructured":"Yang Y, Song J-J, Choi YR et al (2022) Therapeutic functions of astrocytes to treat alpha-synuclein pathology in Parkinson\u2019s disease. Proc Natl Acad Sci U S A 119. https:\/\/doi.org\/10.1073\/PNAS.2110746119","DOI":"10.1073\/PNAS.2110746119"},{"key":"2015_CR61","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/J.NBD.2015.02.031","volume":"78","author":"M Yue","year":"2015","unstructured":"Yue M, Hinkle KM, Davies P et al (2015) Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice. Neurobiol Dis 78:172\u2013195. https:\/\/doi.org\/10.1016\/J.NBD.2015.02.031","journal-title":"Neurobiol Dis"},{"key":"2015_CR62","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.neuron.2004.11.005","volume":"44","author":"A Zimprich","year":"2004","unstructured":"Zimprich A, Biskup S, Leitner P et al (2004) Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 44:601\u2013607. https:\/\/doi.org\/10.1016\/j.neuron.2004.11.005","journal-title":"Neuron"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02015-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-025-02015-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-025-02015-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T09:23:59Z","timestamp":1747041839000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-025-02015-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,12]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2015"],"URL":"https:\/\/doi.org\/10.1186\/s40478-025-02015-x","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,12]]},"assertion":[{"value":"17 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"98"}}